Description

Amilar (dequalinium chloride) lozenges №8

Ingredients

Active ingredient: Dequalinium chloride
Other ingredients: Isomalt, Acesulfame potassium, Peppermint oil, Purified water

Dosage

Adults and children over 6 years: Dissolve 1 lozenge slowly in the mouth every 2-3 hours as needed. Do not exceed 8 lozenges in 24 hours.

Indications

Amilar lozenges are indicated for the relief of sore throat and mouth infections. Dequalinium chloride has antiseptic properties that help in combating bacterial and fungal infections in the mouth and throat.

Contraindications

Do not use Amilar lozenges if you are allergic to dequalinium chloride or any other ingredients in the product. Consult a healthcare professional before use if you are pregnant, breastfeeding, or have any underlying medical conditions.

Directions

Place the lozenge in the mouth and allow it to dissolve slowly without chewing. Do not swallow the lozenge whole. Use as directed by a healthcare provider or follow the instructions on the package.

Scientific Evidence

Dequalinium chloride, the active ingredient in Amilar lozenges, has been extensively studied for its antiseptic properties. Research published in the Journal of Antimicrobial Chemotherapy has shown that dequalinium chloride exhibits broad-spectrum antimicrobial activity against various pathogens, making it effective in treating throat and mouth infections.

Additional Information

It is important to note that Amilar lozenges are for oral use only and should not be swallowed whole. If symptoms persist after using the lozenges as directed, consult a healthcare professional for further evaluation.

Pharmacological Effects: Dequalinium chloride exerts its pharmacological action by disrupting the cell membranes of microorganisms, leading to their death. This mechanism of action helps in eliminating bacteria and fungi that cause throat and mouth infections.

Clinical Trials: Clinical trials have demonstrated the efficacy of dequalinium chloride in reducing the symptoms of sore throat and mouth infections. A study published in the International Journal of Infectious Diseases showed that patients using dequalinium chloride lozenges experienced faster relief compared to those using placebo.